Skip to main content
OpenTrials

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Bladder Cancer trial results

Completed

A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors

NCT02999672

Conditions
Adenocarcinoma, Bladder Cancer, Carcinoma, +22 more
Locations
  • IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola; Oncologia Medica Meldola, Emilia-Romagna, Italy
  • Irccs Ospedale San Raffaele;Oncologia Medica Milan, Lombardy, Italy
  • Irccs Istituto Europeo Di Oncologia (IEO); Cure Mediche Milan, Lombardy, Italy
  • IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima Padova, Veneto, Italy
View all 16 locations
View Trial Details
Completed

A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]

NCT02302807

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Georgetown University Medical Center Lombardi Cancer Center Washington D.C., District of Columbia, United States
  • Emory University; Winship Cancer Institute Atlanta, Georgia, United States
  • Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States
  • Duke Cancer Center Durham, North Carolina, United States
View all 217 locations
View Trial Details

Related conditions